CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Lexicon Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Lexicon Pharmaceuticals | Lexicon Pharmaceuticals, Inc | Lexicon Pharmaceuticals, Inc. | LEXICON PHARMS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2008

First marketed drug

Dec 20, 2007

First NDA

Feb 28, 2017

Last known activity

Jul 1, 2026

Timeline

1990s

  1. Jul 1, 1995

    Lexicon Pharmaceuticals— Founded

2000s

  1. Jun 13, 2001

    Coelacanth Chemical Corporation— Acquired

2020s

  1. May 26, 2023

    sotagliflozin— Marketing Organization

  2. May 26, 2023

    sotagliflozin— NDA Organization

  3. May 26, 2023

    sotagliflozin— NDA Secondary Org

Drugs by trial phase (27 distinct, 56 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (50)

Details

Founded
The Woodlands, TX, US Jul 1, 1995
First NDA
Feb 28, 2017
Last known activity
Jul 1, 2026

Designations held

  • Orphan drug
  • Fast track
  • Priority review